is the optimal boneAbout Nattopharma
NattoPharma is a Norwegian raw material supplier founded in 2004 and based at Lysaker, Norway. The company sells and develops MenaQ7, the natural vitamin K2 which is the most effective form of K2 vitamins. NattoPharma ASA was admitted to the Oslo Stock Exchange list "Oslo Axess" as per January 30th 2008. The company had to fulfil demands with regards to a number of shareholders and equity. These requirements have been satisfied as per January 4th, 2008. Ticker name for the company is NATTO.
NattoPharma has exclusive rights to sell and market Gnosis' natural vitamin K2 products under NattoPharma's brand MenaQ7® into the global Fortified Food and Animal Feed market as well as the European Food Supplement market. Furthermore, NattoPharma and Gnosis has an exclusive Partnership Agreement for the Food Supplement market outside Europe.
Gnosis has a long track record in making high quality vitamin K2 products at their GMP certified Swiss manufacturing facility. They also have a global and well established sales network.
The strategy of NattoPharma is to give priority to investments in patents (IPR), and research and development (R&D). During its short lifetime, NattoPharma has entered into an exclusive R&D alliance with the leading scientific vitamin K expert group in the world, VitaK BV, at the Cardiovascular Research Institute, University of Maastricht, in the Netherlands.
NattoPharma offers superior Vitamin K2 products to customers in the health care, supplement and functional food markets.